Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.77%
1,097.81
-8.55
-0.77%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.29%
612.03
+1.74
+0.29%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.76%
1,220.43
+9.21
+0.76%
—1,211.221,211.011,222.361,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.50%
1,759.52
+8.81
+0.50%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.54%
631.54
+3.37
+0.54%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.30%
857.16
+2.59
+0.30%
—854.57855.71860.09855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.67%
215.41
-1.46
-0.67%
—216.87216.87217.79215.29——
SIXT
Technology
SIXT
Technology
SIXT
+1.47%
3,614.15
+52.21
+1.47%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.55%
908.30
+4.99
+0.55%
—903.31903.26908.38901.18——
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.40
-1.14
-0.08%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.07%
2,398.37
-1.58
-0.07%
—2,399.952,404.452,418.812,396.04——
DEVA:IST
Deva Holding AS
TRY 68.20
+0.15%
(+0.100) 1D
May 14, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for DEVA...
Open
TRY 68.25
High
TRY 69.00
Low
TRY 68.20
Mkt. cap
13.64B
Avg. vol.
719.80K
Volume
362.90K
52-wk high
TRY 81.75
52-wk low
TRY 51.00
EPS
-TRY 4.03
Shares outstanding
200.02M
No. of employees
3K
News stories
From sources across the web
Profile
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market. The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries. Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
About Deva Holding AS
CEO-
Employees3.04K
FoundedSep 22, 1958
Headquarters-
SectorPharmaceutical industry
Websitedeva.com.tr
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TRY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.84B
4.47B
5.49B
5.91B
Cost of goods sold
3.29B
3.02B
3.84B
3.83B
Cost of revenue
3.29B
3.02B
3.84B
3.83B
Research and development expenses
283.92M
264.29M
174.34M
338.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.39B
1.30B
1.58B
1.50B
Operating expense
1.64B
1.55B
1.74B
1.73B
Total operating expenses
4.93B
4.58B
5.58B
5.56B
Operating income
-88.02M
-102.14M
-89.10M
347.87M
Other non operating income
808.89M
337.87M
185.09M
631.66M
EBT including unusual items
197.34M
-137.34M
-340.89M
547.01M
EBT excluding unusual items
205.01M
-137.34M
-362.51M
548.03M
Income tax expense
-340.99M
-116.52M
1.00B
637.90M
Effective tax rate
-172.79%
84.84%
-294.28%
116.62%
Other operating expenses
-38.46M
-9.80M
-11.48M
-106.09M
Net income
538.34M
-20.81M
-1.34B
-90.89M
Net profit margin
11.12%
-0.47%
-24.48%
-1.54%
Earnings per share
-
-
-
-
Interest and investment income
159.53M
59.54M
23.47M
90.04M
Interest expense
-802.12M
-617.63M
-656.70M
-521.54M
Net interest expenses
-642.59M
-558.09M
-633.23M
-431.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
183.35M
237.92M
622.26M
860.71M
Gain or loss from assets sale
-12.26M
-15.06M
-15.93M
-32.28M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer